The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease

Background and Objectives: Alpha 1-antitrypsin deficiency (AATD) is one of the genetic risk factors in the patients suffering from chronic obstructive pulmonary disease (COPD). The exact number of Iranians suffering from this disease is yet not known. Therefore, the aim of this study was to determin...

Full description

Bibliographic Details
Main Authors: Basiri Z, Abdoli S, Hajilui M, Nadi E
Format: Article
Language:fas
Published: Qom University of Medical Sciences 2011-03-01
Series:Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum
Subjects:
Online Access:http://journal.muq.ac.ir/library/upload/article/af_359733390.17.2.pdf
_version_ 1811200684648824832
author Basiri Z
Abdoli S
Hajilui M
Nadi E
author_facet Basiri Z
Abdoli S
Hajilui M
Nadi E
author_sort Basiri Z
collection DOAJ
description Background and Objectives: Alpha 1-antitrypsin deficiency (AATD) is one of the genetic risk factors in the patients suffering from chronic obstructive pulmonary disease (COPD). The exact number of Iranians suffering from this disease is yet not known. Therefore, the aim of this study was to determine the prevalence of the deficiency of AAT enzyme in patients suffering from COPD. Methods: The topical test of AAT serum was conducted on 125 patients affected by COPD who had referred to Ekbatan Hospital of Hamadan in 2007. The diagnoses of COPD in these patients dad been confirmed through history and spirometerty test before and after bronchodilator inhalation and the outcomes had been confirmed based on GOLD regulations. In other words, after separation of serum from blood, the specific antibody of AAT was added to the sample. The AAT serum level was read according to nephelometry measurement and the results were given in g/L. The gathered data were then analyzed using SPSS software program and statistical tests such as T-test and 2 (p<0.05). Results: Out of 125 patients, 91 were male and 34 patients were female (2.7/1). The mean age was 6312 years and the mean AAT serum in the patients was between 0.710g/L and 2.696g/L (mean 1.3110.364g/L). Almost all of the male patients had history of smoking (91%) and this smoking and its dose (Pack/Year) were significantly related to the severity of COPD. There was no significant relation between plasma levels of AAT and smoking, age or sex. The average age of patients suffering from COPD in rational AAT deficiency was significantly lower. However, the severity of symptoms had no significant difference between patients with normal levels of AAT.Conclusion: Based on the findings of this study, no case of exact deficiency of AAT was found in patients suffering from COPD admitted to Ekbatan Hospital of Hamadan. Regarding geographical location and number of the samples, the possibility of prevalence of this disease in Hamadan is much lower than that of European countries. However, the relative deficiency of AAT (20% in this study) was higher than the amounts obtained from similar studies in European countries.
first_indexed 2024-04-12T02:07:59Z
format Article
id doaj.art-83af401c45584fd1b5b414cf4e841213
institution Directory Open Access Journal
issn 1735-7799
2008-1375
language fas
last_indexed 2024-04-12T02:07:59Z
publishDate 2011-03-01
publisher Qom University of Medical Sciences
record_format Article
series Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum
spelling doaj.art-83af401c45584fd1b5b414cf4e8412132022-12-22T03:52:29ZfasQom University of Medical SciencesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum1735-77992008-13752011-03-0151711The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary DiseaseBasiri ZAbdoli SHajilui MNadi EBackground and Objectives: Alpha 1-antitrypsin deficiency (AATD) is one of the genetic risk factors in the patients suffering from chronic obstructive pulmonary disease (COPD). The exact number of Iranians suffering from this disease is yet not known. Therefore, the aim of this study was to determine the prevalence of the deficiency of AAT enzyme in patients suffering from COPD. Methods: The topical test of AAT serum was conducted on 125 patients affected by COPD who had referred to Ekbatan Hospital of Hamadan in 2007. The diagnoses of COPD in these patients dad been confirmed through history and spirometerty test before and after bronchodilator inhalation and the outcomes had been confirmed based on GOLD regulations. In other words, after separation of serum from blood, the specific antibody of AAT was added to the sample. The AAT serum level was read according to nephelometry measurement and the results were given in g/L. The gathered data were then analyzed using SPSS software program and statistical tests such as T-test and 2 (p<0.05). Results: Out of 125 patients, 91 were male and 34 patients were female (2.7/1). The mean age was 6312 years and the mean AAT serum in the patients was between 0.710g/L and 2.696g/L (mean 1.3110.364g/L). Almost all of the male patients had history of smoking (91%) and this smoking and its dose (Pack/Year) were significantly related to the severity of COPD. There was no significant relation between plasma levels of AAT and smoking, age or sex. The average age of patients suffering from COPD in rational AAT deficiency was significantly lower. However, the severity of symptoms had no significant difference between patients with normal levels of AAT.Conclusion: Based on the findings of this study, no case of exact deficiency of AAT was found in patients suffering from COPD admitted to Ekbatan Hospital of Hamadan. Regarding geographical location and number of the samples, the possibility of prevalence of this disease in Hamadan is much lower than that of European countries. However, the relative deficiency of AAT (20% in this study) was higher than the amounts obtained from similar studies in European countries.http://journal.muq.ac.ir/library/upload/article/af_359733390.17.2.pdfAlpha 1-Antitypsin DeficiencyLung DiseaseObstructiveSmokingOccupational Diseases.
spellingShingle Basiri Z
Abdoli S
Hajilui M
Nadi E
The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum
Alpha 1-Antitypsin Deficiency
Lung Disease
Obstructive
Smoking
Occupational Diseases.
title The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease
title_full The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease
title_fullStr The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease
title_full_unstemmed The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease
title_short The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease
title_sort prevalence of the alpha 1 antitrypsin deficiency in patients with chronic obstructive pulmonary disease
topic Alpha 1-Antitypsin Deficiency
Lung Disease
Obstructive
Smoking
Occupational Diseases.
url http://journal.muq.ac.ir/library/upload/article/af_359733390.17.2.pdf
work_keys_str_mv AT basiriz theprevalenceofthealpha1antitrypsindeficiencyinpatientswithchronicobstructivepulmonarydisease
AT abdolis theprevalenceofthealpha1antitrypsindeficiencyinpatientswithchronicobstructivepulmonarydisease
AT hajiluim theprevalenceofthealpha1antitrypsindeficiencyinpatientswithchronicobstructivepulmonarydisease
AT nadie theprevalenceofthealpha1antitrypsindeficiencyinpatientswithchronicobstructivepulmonarydisease
AT basiriz prevalenceofthealpha1antitrypsindeficiencyinpatientswithchronicobstructivepulmonarydisease
AT abdolis prevalenceofthealpha1antitrypsindeficiencyinpatientswithchronicobstructivepulmonarydisease
AT hajiluim prevalenceofthealpha1antitrypsindeficiencyinpatientswithchronicobstructivepulmonarydisease
AT nadie prevalenceofthealpha1antitrypsindeficiencyinpatientswithchronicobstructivepulmonarydisease